Treatment of urticaria and angioedema: Low-sedating H1-type antihistamines
- 30 June 1991
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 24 (6) , 1084-1087
- https://doi.org/10.1016/0190-9622(91)70161-t
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Recent advances in H1-receptor antagonist treatmentJournal of Allergy and Clinical Immunology, 1990
- Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticariaJournal of the American Academy of Dermatology, 1988
- Loratadine: A Potent, Nonsedating, and Long-Acting H1 AntagonistAmerican Journal of Rhinology, 1987
- Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedemaJournal of the American Academy of Dermatology, 1987
- The treatment of mild to severe chronic idiopathic urticaria with astemizole: Double-blind and open trialsJournal of Allergy and Clinical Immunology, 1986
- Efficacy and safety of astemizole, a long-acting and nonsedating H antagonist for the treatment of chronic idiopathic urticariaJournal of Allergy and Clinical Immunology, 1986
- AstemizoleDrugs, 1984
- The effect of terfenadine on dermographic wealingBritish Journal of Dermatology, 1984
- Evaluation of six antihistamines in vitro and in patients with urticariaClinical and Experimental Dermatology, 1982
- Physical urticaria/angioedema as an experimental model of acute and chronic inflammation in human skinSpringer Seminars in Immunopathology, 1981